Berger Dietmar 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Berger Dietmar（CIK 1739515）在 1 家公司共报告 9 笔 SEC Form 4 内部人交易（最近一笔 2026-09-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-11 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 买入 | 533 | $0 |
| 2026-09-11 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 卖出 | 263 | $38,085 |
| 2026-06-11 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 买入 | 533 | $0 |
| 2026-06-11 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 卖出 | 263 | $31,949 |
| 2026-03-12 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 买入 | 2,133 | $0 |
| 2026-03-12 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 卖出 | 1,063 | $157,919 |
| 2026-03-02 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 买入 | 8,530 | $0 |
| 2026-01-05 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 买入 | 16,326 | $0 |
| 2026-01-05 | GILEAD SCIENCES, INC. (GILD) | Chief Medical Officer | 卖出 | 6,944 | $844,390 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11